BRCA2 Antikörper (pSer3291)
Kurzübersicht für BRCA2 Antikörper (pSer3291) (ABIN4880014)
Target
Alle BRCA2 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
Klon
-
-
Bindungsspezifität
- pSer3291
-
Verwendungszweck
- BRCA2 (pSer3291) [P-CS-4]
-
Spezifität
- Phosphorylated BRCA2 (pSer3291)
-
Aufreinigung
- Peptide affinity chromatography
-
Immunogen
- Synthetic peptide linked to KLH
-
-
anti-Breast Cancer 2, Early Onset (BRCA2) (AA 21-130) antibody
BRCA2 Reaktivität: Human WB, ELISA, IHC (p), IHC (fro), IF (cc), IF (p) Wirt: Kaninchen Polyclonal unconjugated
anti-Breast Cancer 2, Early Onset (BRCA2) antibodyBRCA2 Reaktivität: Human, Ratte WB, IHC, IF Wirt: Kaninchen Polyclonal unconjugated
anti-Breast Cancer 2, Early Onset (BRCA2) (AA 2990-3232) antibodyBRCA2 Reaktivität: Maus WB, IHC, IP, ICC Wirt: Kaninchen Polyclonal unconjugated
anti-Breast Cancer 2, Early Onset (BRCA2) (AA 3319-3418) antibodyBRCA2 Reaktivität: Human WB, ELISA Wirt: Maus Monoclonal 3D12 unconjugated
anti-Breast Cancer 2, Early Onset (BRCA2) (AA 1-300) antibodyBRCA2 Reaktivität: Human WB, IF Wirt: Kaninchen Polyclonal unconjugated
anti-Breast Cancer 2, Early Onset (BRCA2) (AA 2913-3151) antibodyBRCA2 Reaktivität: Ratte WB, IHC, IP, ICC Wirt: Kaninchen Polyclonal unconjugated
anti-Breast Cancer 2, Early Onset (BRCA2) (AA 251-495) antibodyBRCA2 Reaktivität: Human WB Wirt: Maus Monoclonal 1643CT739-91-87 unconjugated
anti-Breast Cancer 2, Early Onset (BRCA2) (AA 2308-2537) antibodyBRCA2 Reaktivität: Human WB Wirt: Kaninchen Polyclonal unconjugated
anti-Breast Cancer 2, Early Onset (BRCA2) (AA 2737-2874) antibodyBRCA2 Reaktivität: Zebrafisch (Danio rerio) WB, ELISA Wirt: Kaninchen Polyclonal unconjugated
anti-Breast Cancer 2, Early Onset (BRCA2) (C-Term) antibodyBRCA2 Reaktivität: Human WB, IP Wirt: Kaninchen Polyclonal unconjugated
-
-
Applikationshinweise
- Optimal antibody dilution should be determined by titration, however as a guideline start at 1 μg/mL for western blot
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 0.36 mg/mL
-
Buffer
- PBS 0.09 % sodium azide
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
-
- BRCA2 (Breast Cancer 2, Early Onset (BRCA2))
-
Andere Bezeichnung
- BRCA2
-
Hintergrund
- BRCA 2 antibody,BRCA1/BRCA2 containing complex subunit 2 antibody,Brca2 antibody,BRCA2_HUMAN antibody,BRCC 2 antibody,BRCC2 antibody,Breast and ovarian cancer susceptibility gene early onset antibody,Breast cancer 2 early onset antibody,Breast Cancer 2 tumor suppressor antibody,Breast cancer susceptibility protein BRCA2 antibody,Breast cancer type 2 susceptibility protein antibody,BROVCA2 antibody,FACD antibody,FAD 1 antibody,FAD antibody,FAD1 antibody,FANCB antibody,FANCD 1 antibody,FANCD antibody,FANCD1 antibody,Fanconi anemia complementation group D1 antibod,Fanconi anemia group D1 protein antibody,GLM3 antibody,OTTHUMP00000018803 antibody,OTTHUMP00000042401 antibody
-
Gen-ID
- 675
-
Pathways
- DNA Reparatur, M Phase, Maintenance of Protein Location
Target
-
